TXG

10x Genomics Inc

80.70

Sep 22 • 3:59 PM ET +1.60 (2.02%)

81.30

Aftermarket • 7:44 PM ET +0.60 (0.74%)

Healthcare Medical Devices USA Large NASD

Peers: RGEN TECH TWST A BIO BRKR MTD WAT DHR TMO

| Held by: ARKE ARKK IWM VTI ARKG VB VBK IWO VXF IBB

Scroll to Statements

Index	RUT
Market Cap	10.51B
Enterprise Value	10.04B
Income	-75.12M
Sales	616.91M
Book/sh	6.34
Cash/sh	4.24
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	1178
IPO	Sep 12, 2019

P/E	-
Forward P/E	-
PEG	-
P/S	17.04
P/B	12.74
P/C	19.05
P/FCF	86.58
EV/EBITDA	-
EV/Sales	16.28
Quick Ratio	5.25
Current Ratio	5.69
Debt/Eq	0.10
LT Debt/Eq	0.08
Option/Short	Yes / Yes

EPS (ttm)	-0.59
EPS next Y	-0.73
EPS next Q	-0.26
EPS this Y	-111.26%
EPS next Y	1.15%
EPS next 5Y	-7.42%
EPS past 3/5Y	37.90% 42.10%
Sales past 3/5Y	7.57% 16.55%
EPS Y/Y TTM	15.82%
Sales Y/Y TTM	-4.28%
EPS Q/Q	-149.75%
Sales Q/Q	-12.65%
Earnings	Aug 06 AMC
EPS/Sales Surpr.	42.41% 2.97%

Insider Own	10.88%
Insider Trans	-1.85%
Inst Own	105.65%
Inst Trans	7.36%
ROA	-7.47%
ROE	-9.40%
ROIC	-8.42%
Gross Margin	70.58%
Oper. Margin	-14.12%
Profit Margin	-12.18%
SMA20	18.35%
SMA50	38.71%
SMA200	152.60%
Trades

Shs Outstand	120.20M
Shs Float	116.12M
Short Float	13.92%
Short Ratio	5.27
Short Interest	16.16M
52W High	80.11 0.74%
52W Low	11.16 623.12%
Volatility	6.10% 6.06%
ATR (14)	4.24
RSI (14)	77.41
Beta	2.05
Rel Volume	1.27
Avg Volume	3.07M
Volume	3,890,700

Perf Week	8.48%
Perf Month	23.93%
Perf Quarter	153.22%
Perf Half Y	321.63%
Perf YTD	394.79%
Perf Year	518.87%
Perf 3Y	95.16%
Perf 5Y	-49.17%
Perf 10Y	-
Recom	2.44
Target Price	56.60
Prev Close	79.10
Price	80.70
Change %	2.02%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-26	Resumed	UBS	Neutral	$68
Sep-01-26	Initiated	RBC Capital Mkts	Sector Perform	$70
Mar-31-26	Upgrade	William Blair	Mkt Perform → Outperform
Dec-11-25	Downgrade	Citigroup	Buy → Neutral
Dec-02-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$20
Sep-11-25	Initiated	Piper Sandler	Neutral	$15
Feb-13-25	Downgrade	Leerink Partners	Outperform → Market Perform	$25 → $12
Sep-03-24	Initiated	Leerink Partners	Outperform	$35
Jul-22-24	Upgrade	Jefferies	Hold → Buy	$24
Jul-18-24	Downgrade	JP Morgan	Overweight → Neutral	$40 → $20
Jul-10-24	Downgrade	Deutsche Bank	Buy → Hold	$55 → $25
Jun-27-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Jun-25-24	Downgrade	Guggenheim	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Hold	$24
May-01-24	Downgrade	TD Cowen	Buy → Hold	$57 → $32
Dec-14-23	Initiated	Guggenheim	Buy	$60
Dec-13-23	Initiated	Wolfe Research	Outperform	$55
Dec-12-23	Upgrade	BofA Securities	Underperform → Neutral	$36 → $54
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-10-23	Initiated	Barclays	Overweight	$65

Show Previous Ratings

Today 07:10AM	Beyond Meta, Cathie Woods ARKG Loads Up On These 4 Biotech Names (Stocktwits)
Sep-18-26 05:38PM	The ARK Trade Watch: Cathie Wood Cuts Crypto Exposure, Then Reverses Course On CoreWeave (Stocktwits)
Sep-15-26 08:19AM	Cathie Wood Makes Striking Switch Between AI Stock Giants (GuruFocus.com) +6.10%
Aug-28-26 02:38PM	10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences (PR Newswire) -5.10%
Aug-07-26 08:30AM	10x Genomics, Inc. Q2 2026 Earnings Call Summary (Moby) +14.10%
04:12PM	Loading…
Aug-06-26 04:12PM	10x Genomics: Q2 Earnings Snapshot (Associated Press)
04:02PM	10x Genomics Reports Second Quarter 2026 Financial Results (PR Newswire)
Jul-29-26 09:00AM	10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care (PR Newswire)
Jul-20-26 12:06PM	Cathie Wood Dumps $39 Million Worth of AMD Stock (GuruFocus.com)
Jul-15-26 04:05PM	10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026 (PR Newswire)
07:41AM	Cathie Woods ARK Invest Doubles Down On Circle In Two Funds At Once, Trims Robinhood Again (Stocktwits)
Jul-13-26 12:52PM	Cathie Wood Loads Up on SpaceX, Meta, Eli Lilly and Circle Group (GuruFocus.com)
Jun-17-26 09:00AM	10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer (PR Newswire)
Jun-15-26 02:48PM	Cathie Wood Buys $444 Million in SpaceX, Dumps Tesla and AMD (GuruFocus.com) +11.72%
Jun-09-26 09:00AM	10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group (PR Newswire)
08:55PM	Loading…
May-07-26 08:55PM	10x Genomics, Inc. Q1 2026 Earnings Call Summary (Moby)
04:34PM	10x Genomics: Q1 Earnings Snapshot (Associated Press)
04:05PM	10x Genomics Reports First Quarter 2026 Financial Results (PR Newswire)
Apr-29-26 04:05PM	10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference (PR Newswire) -5.47% +9.16%
Apr-18-26 10:00PM	10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood (PR Newswire)
Apr-15-26 04:05PM	10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026 (PR Newswire)
Apr-09-26 06:00PM	Torex Gold Reports Q1 2026 Production Results (TMX Newsfile)
Apr-07-26 06:00PM	Torex Gold Welcomes Jacques Perron to Its Board of Directors (TMX Newsfile) +5.50%
Mar-31-26 09:32AM	Western Digital upgraded, PayPal initiated: Wall Street's top analyst calls (The Fly) +7.17%
04:00AM	Merck strikes deal with antibody discovery startup (BioPharma Dive)
Mar-25-26 07:00AM	Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs (PR Newswire) +5.55%
Mar-24-26 06:00PM	Torex Gold Reports Year-End 2025 Reserves & Resources (TMX Newsfile)
Mar-17-26 08:00AM	PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas (PR Newswire) +8.39%
Mar-09-26 08:52AM	Should You Buy, Hold or Sell Tempus AI Stock Heading Into 2026? (Zacks)
Mar-05-26 10:41PM	Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers (StockStory)
10:15AM	Loading…
Mar-03-26 10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-19-26 04:05PM	10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference (PR Newswire)
12:38AM	5 Must-Read Analyst Questions From 10x Genomics's Q4 Earnings Call (StockStory)
Feb-18-26 09:41AM	Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy? (Zacks) +5.10%
Feb-13-26 11:30AM	Why Is 10x Genomics (TXG) Stock Soaring Today (StockStory)
08:30AM	10x Genomics, Inc. Q4 2025 Earnings Call Summary (Moby)
12:32AM	TXG Q4 Deep Dive: Consumables Growth, Spatial Expansion, and AI-Driven Demand Shape Outlook (StockStory)
12:04AM	10x Genomics Inc (TXG) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations Amid ... (GuruFocus.com)
Feb-12-26 09:07PM	10x Genomics Q4 Earnings Call Highlights (MarketBeat) -8.56%
06:30PM	Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics (Zacks)
05:30PM	10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:54PM	10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 (StockStory)
04:30PM	10x Genomics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 (PR Newswire)
Feb-10-26 10:07PM	10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-05-26 10:00AM	10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks) -7.14%
Feb-04-26 09:00AM	PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology (PR Newswire)
Jan-30-26 02:48PM	Gold, Silver Crash Sparks Mining Meltdown: 10 Stocks Crater On Fed Warsh Shock (Benzinga)
Jan-22-26 04:05PM	10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (PR Newswire)
03:47AM	Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell (Zacks)
Jan-21-26 04:58PM	Cathie Wood Has 13 Big Ideas For 2026: Here's The Ark Invest List And Stocks To Watch (Benzinga)
09:53AM	3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes (Zacks)
Jan-20-26 12:05AM	Cathie Wood's Ark Unleashes Cryptic ARKmoji Teasers To Showcase Its 'Big Ideas' For 2026: Can You Take A Guess At The Hidden Meaning? (Benzinga) +7.46%
Jan-19-26 01:27PM	Cathie Wood Buys AI Chips, Sells Tesla (GuruFocus.com)
Jan-18-26 11:40PM	3 Hyped Up Stocks That Concern Us (StockStory)
Jan-12-26 04:05PM	Why 10x Genomics (TXG) Shares Are Falling Today (StockStory)
09:11AM	10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease (PR Newswire)
09:10AM	10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling (PR Newswire)
09:00AM	Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology (PR Newswire)
Jan-11-26 12:00PM	10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results (PR Newswire)
Jan-07-26 07:05AM	CareDx and 10x Genomics to Launch ImmuneScape Program - A Multiomics Research Platform to Decode Transplant Rejection and Drug Response (Business Wire)
Jan-02-26 01:45PM	10x Genomics (TXG) Stock Is Up, What You Need To Know (StockStory)
Dec-29-25 04:05PM	10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-22-25 10:20PM	Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending (Insider Monkey) +5.55%
11:56AM	10x Genomics (TXG) Stock Trades Up, Here Is Why (StockStory)
Dec-17-25 11:22AM	Tempus AI Turns Non-GAAP Profit on Surging Genomics and Data (Zacks)
Dec-16-25 09:07AM	Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up (Zacks)
Dec-15-25 11:30AM	Tempus AI Near $75 Target? Valuation, Upside and Risks (Zacks)
Dec-11-25 11:41AM	Why 10x Genomics (TXG) Stock Is Nosediving (StockStory) -5.65%
Dec-07-25 10:32PM	Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders (StockStory)
Dec-02-25 09:34AM	Teradyne upgraded, Circle Internet initiated: Wall Street's top analyst calls (The Fly)
Nov-18-25 11:02PM	3 Reasons to Avoid TXG and 1 Stock to Buy Instead (StockStory)
09:00AM	New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium (PR Newswire)
Nov-15-25 11:42PM	10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch (Insider Monkey)
Nov-13-25 12:33AM	5 Insightful Analyst Questions From 10x Genomics's Q3 Earnings Call (StockStory)
Nov-11-25 04:05PM	10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 (PR Newswire)
12:51PM	10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat (Insider Monkey)
12:26PM	Why 10x Genomics (TXG) Stock Is Trading Up Today (StockStory)
07:29AM	Should You Buy, Hold or Sell TEM Stock Post Q3 Earnings Release? (Zacks)
Nov-07-25 04:06PM	Why 10x Genomics (TXG) Stock Is Trading Up Today (StockStory) +17.31% +12.00%
09:26AM	TXG Q3 Deep Dive: Spatial Biology and Consumables Drive Outperformance Amid Macro Uncertainty (StockStory)
06:36AM	Stock Market Today: U.S. Stock Futures Tumble After Overnight Reprieve, Extending Week-Long Tech Struggle (TheStreet)
Nov-06-25 07:00PM	Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:57PM	10x Genomics's (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% (StockStory)
04:52PM	10x Genomics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-05-25 05:41AM	Qiagen inks $225M single-cell buyout as CEO prepares to step down (MedTech Dive)
Nov-04-25 10:17PM	10x Genomics Earnings: What To Look For From TXG (StockStory)
Oct-30-25 10:00AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-29-25 01:39PM	Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings? (Zacks)
09:00AM	10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research (PR Newswire)
Oct-21-25 05:19AM	10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? (Zacks)
Oct-20-25 12:30PM	10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences (PR Newswire) +11.07%
11:35AM	Why Is 10x Genomics (TXG) Stock Rocketing Higher Today (StockStory)
11:23AM	Zacks.com featured highlights include Red Robin Gourmet Burgers, 10x Genomics, Norwegian Cruise Line, Electromed and Analog Devices (Zacks)
10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks)
09:03AM	Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy? (Zacks)
Oct-17-25 11:05AM	5 Must-Buy Efficient Stocks to Increase Your Portfolio Returns (Zacks)
Oct-16-25 12:00PM	10x Genomics (TXG) Upgraded to Strong Buy: Here's What You Should Know (Zacks)

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Co-FounderDr. Serge Saxonov Ph.D.

Co-FounderDr. Benjamin J. Hindson Ph.D.

CFOMr. Adam S. Taich

Chief of Global OperationsMr. Jim Goodrich

Founding Scientist & CTOMr. Michael Schnall-Levin Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Shehnaaz Suliman	Affiliate	Sep 22 '26	Proposed Sale	79.10	5,723	452,689		Sep 22 06:27 PM
Taich Adam	Chief Financial Officer	Sep 09 '26	Sale	64.57	46,388	2,995,470	316,344	Sep 11 04:47 PM
ADAM TAICH	Officer	Sep 09 '26	Proposed Sale	64.57	46,388	2,995,470		Sep 09 04:28 PM
STUELPNAGEL JOHN R	Director	Sep 03 '26	Sale	61.75	20,000	1,235,072	328,436	Sep 08 07:00 PM
STUELPNAGEL JOHN R	Director	Sep 03 '26	Proposed Sale	61.75	20,000	1,235,046		Sep 03 02:28 PM
Saxonov Serge	Chief Executive Officer	Aug 26 '26	Sale	63.69	10,486	667,901	1,075,349	Aug 28 07:22 PM
Serge Saxonov	Director, CEO	Aug 26 '26	Proposed Sale	62.18	35,486	2,206,654		Aug 26 06:09 PM
Saxonov Serge	Chief Executive Officer	Aug 24 '26	Sale	63.02	18,545	1,168,775	1,085,835	Aug 26 04:46 PM
Taich Adam	Chief Financial Officer	Aug 24 '26	Sale	63.02	17,166	1,081,853	362,732	Aug 26 04:44 PM
Hindson Benjamin J.	See Remarks	Aug 24 '26	Sale	63.02	13,818	870,860	488,182	Aug 26 04:43 PM
SULIMAN SHEHNAAZ	Director	Aug 24 '26	Sale	63.65	2,207	140,478	29,515	Aug 26 04:42 PM
Taich Adam	Officer	Aug 24 '26	Proposed Sale	65.12	16,614	1,081,904		Aug 24 06:53 PM
Saxonov Serge	Officer	Aug 24 '26	Proposed Sale	65.12	17,948	1,168,774		Aug 24 06:24 PM
Hindson Benjamin J.	Officer	Aug 24 '26	Proposed Sale	65.12	13,373	870,850		Aug 24 06:05 PM
Shehnaaz Suliman	Affiliate	Aug 24 '26	Proposed Sale	65.12	2,207	143,720		Aug 24 05:27 PM
Teichmann Sarah A.	Director	Aug 13 '26	Sale	57.29	5,278	302,377	30,331	Aug 17 04:08 PM
Teichmann Sarah A.	Director	Aug 14 '26	Sale	57.15	2,273	129,902	28,058	Aug 17 04:08 PM
SARAH A POLONIUS-TEICHMANN	Director	Aug 14 '26	Proposed Sale	57.15	2,273	129,902		Aug 14 04:35 PM
SARAH A POLONIUS-TEICHMANN	Director	Aug 13 '26	Proposed Sale	57.29	5,278	302,377		Aug 13 04:16 PM
STUELPNAGEL JOHN R	Director	Aug 11 '26	Sale	57.75	20,000	1,155,055	348,436	Aug 13 04:11 PM
STUELPNAGEL JOHN R	Director	Aug 11 '26	Proposed Sale	57.75	20,000	1,155,032		Aug 11 12:04 PM
Saxonov Serge	Chief Executive Officer	Jun 22 '26	Sale	34.44	30,000	1,033,269	1,108,380	Jun 24 04:22 PM
SULIMAN SHEHNAAZ	Director	Jun 16 '26	Sale	32.63	5,723	186,756	31,722	Jun 18 04:08 PM
Shehnaaz Suliman	Affiliate	Jun 16 '26	Proposed Sale	32.22	5,723	184,395		Jun 16 07:58 PM
Saxonov Serge	Chief Executive Officer	May 22 '26	Sale	24.44	18,175	444,224	1,149,098	May 27 05:57 PM
Saxonov Serge	Chief Executive Officer	May 26 '26	Sale	24.71	10,718	264,833	1,138,380	May 27 05:57 PM
Hindson Benjamin J.	See Remarks	May 22 '26	Sale	24.44	11,595	283,399	502,000	May 27 05:56 PM
Taich Adam	Chief Financial Officer	May 22 '26	Sale	24.44	15,098	369,018	379,898	May 27 05:55 PM
Serge Saxonov	Director, CEO	May 26 '26	Proposed Sale	23.68	40,718	964,202		May 26 04:56 PM
Saxonov Serge	Officer	May 22 '26	Proposed Sale	24.68	17,948	442,957		May 22 08:31 PM
Hindson Benjamin J.	Officer	May 22 '26	Proposed Sale	24.68	9,430	232,732		May 22 06:26 PM
Taich Adam	Officer	May 22 '26	Proposed Sale	24.68	11,779	290,706		May 22 05:40 PM
Saxonov Serge	Chief Executive Officer	Apr 14 '26	Sale	24.56	5,000	122,784	1,167,273	Apr 16 04:07 PM
Saxonov Serge	Chief Executive Officer	Mar 23 '26	Sale	19.13	10,000	191,297	1,177,273	Mar 25 05:15 PM
Saxonov Serge	Chief Executive Officer	Mar 24 '26	Sale	19.52	5,000	97,612	1,172,273	Mar 25 05:15 PM
Saxonov Serge	Chief Executive Officer	Mar 02 '26	Sale	22.73	16,152	367,097	1,203,667	Mar 04 04:14 PM
Serge Saxonov	Director, CEO	Mar 02 '26	Proposed Sale	22.13	41,152	910,694		Mar 02 04:21 PM
Teichmann Sarah A.	Director	Feb 25 '26	Sale	19.41	7,579	147,108	26,780	Feb 27 04:01 PM
Saxonov Serge	Chief Executive Officer	Feb 23 '26	Sale	18.58	9,632	178,928	1,061,924	Feb 25 04:52 PM
Taich Adam	Chief Financial Officer	Feb 23 '26	Sale	18.58	8,968	166,593	288,417	Feb 25 04:51 PM
Hindson Benjamin J.	See Remarks	Feb 23 '26	Sale	18.58	7,826	145,379	424,779	Feb 25 04:51 PM
SARAH A POLONIUS-TEICHMANN	Director	Feb 25 '26	Proposed Sale	19.41	7,579	147,108		Feb 25 04:44 PM
Hindson Benjamin J.	Officer	Feb 23 '26	Proposed Sale	19.19	8,301	159,269		Feb 23 05:30 PM
Saxonov Serge	Officer	Feb 23 '26	Proposed Sale	19.19	10,129	194,376		Feb 23 05:15 PM
Taich Adam	Officer	Feb 23 '26	Proposed Sale	19.19	9,188	176,318		Feb 23 05:00 PM
Saxonov Serge	Chief Executive Officer	Jan 05 '26	Option Exercise	1.20	50,000	60,000	1,071,556	Jan 07 04:52 PM
Taich Adam	Chief Financial Officer	Nov 24 '25	Sale	19.00	11,888	225,852	297,385	Nov 25 05:24 PM
Hindson Benjamin J.	See Remarks	Nov 24 '25	Sale	19.00	8,283	157,363	432,605	Nov 25 05:24 PM
Saxonov Serge	Chief Executive Officer	Nov 24 '25	Sale	19.00	13,261	251,936	1,021,556	Nov 25 05:23 PM
Hindson Benjamin J.	Officer	Nov 24 '25	Proposed Sale	18.34	7,392	135,569		Nov 24 05:32 PM
Saxonov Serge	Officer	Nov 24 '25	Proposed Sale	18.34	13,096	240,181		Nov 24 04:56 PM
Taich Adam	Officer	Nov 24 '25	Proposed Sale	18.34	11,312	207,462		Nov 24 04:28 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TXG

10x Genomics Inc

Upgrade your Finviz experience